Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Choosing Therapy For Stage 4 Pancreatic Cancer: What Are The Criteria?
By Robert A. Nagourney, MD
Pancreatic cancer afflicts 53,000 patients each year in the U.S. and has overtaken breast cancer as the third leading cause of cancer death in the United States.    While newer chemotherapy combinations have had some impact, the gains have...
Ovarian Cancer Therapy
By Robert A. Nagourney, MD
For many years I have been interested in the ovarian cancer literature. After all, it was our group that originally developed...
The Avastin Saga Continues
By Robert A. Nagourney, MD
We previously wrote about bevacizumab (Avastin) and its approval for breast cancer. The early clinical trials revealed evidence...
PARP Inhibitors in Breast Cancer? What happened?
By Robert A. Nagourney, MD
Many of you may recall that we described our studies with the small molecules BSI201 (iniparib) and AZD2281 (olaparib)...
A Tale of Two Lung Cancers - Personalized Cancer Therapy Successes
By Robert A. Nagourney, MD
I was recently asked to speak at a community outreach mixer to describe our work in lung cancer. I invited two patients to join...
What Can We Offer Patients For Pancreatic Cancer Survival?
By Robert A. Nagourney, MD
Recently, I received a call from a previous patient for whom I was not the treating oncologist. Originally, she had heard about...

browse by topic

Select A topic

View All Topics

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.